{"filing":{"accession_number":"0001477449-26-000044","cik":"0001477449","ticker":"TDOC","company_name":"Teladoc Health, Inc.","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-27","primary_document":"tdoc-20260827.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744926000044/tdoc-20260827.htm"},"events":[{"id":30652,"run_id":28100,"accession_number":"0001477449-26-000044","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Michael Grasher was appointed as Chief Financial Officer of Teladoc Health effective August 31, 2026, replacing interim CFO Charles Divita III. The appointment includes a $550,000 base salary, $500,000 sign-on bonus, and $3,000,000 in equity awards, reflecting his extensive financial leadership experience including prior CFO roles at AMERISAFE, Fortegra, and IFG Companies.","company_name":"Teladoc Health, Inc.","ticker":"TDOC","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":[{"id":33307,"accession_number":"0001477449-26-000044","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Michael Grasher was appointed as Chief Financial Officer of Teladoc Health effective August 31, 2026, replacing Charles Divita III who served as interim principal financial officer. This is a material executive appointment of a named officer to a principal financial role, with detailed compensation arrangements including $550,000 base salary, $500,000 sign-on bonus, and $3,000,000 in equity awards. The appointment of a permanent CFO is material to investors assessing the company's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:38:00.925278+00:00","company_name":"","ticker":null,"filing_date":""},{"id":33308,"accession_number":"0001477449-26-000044","item_number":"7.01","item_title":"Regulation FD.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Michael Grasher as Chief Financial Officer of Teladoc Health, effective immediately on August 31, 2026. The press release emphasizes his extensive financial leadership experience across public and private companies, including prior CFO roles at AMERISAFE (publicly traded), Fortegra, and IFG Companies. This is a material executive appointment to a C-suite officer position responsible for financial reporting, planning, and capital management.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:38:00.925278+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33307,"accession_number":"0001477449-26-000044","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Michael Grasher was appointed as Chief Financial Officer of Teladoc Health effective August 31, 2026, replacing Charles Divita III who served as interim principal financial officer. This is a material executive appointment of a named officer to a principal financial role, with detailed compensation arrangements including $550,000 base salary, $500,000 sign-on bonus, and $3,000,000 in equity awards. The appointment of a permanent CFO is material to investors assessing the company's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:38:00.925278+00:00","company_name":"Teladoc Health, Inc.","ticker":"TDOC","filing_date":"2026-08-31"},{"id":33308,"accession_number":"0001477449-26-000044","item_number":"7.01","item_title":"Regulation FD.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Michael Grasher as Chief Financial Officer of Teladoc Health, effective immediately on August 31, 2026. The press release emphasizes his extensive financial leadership experience across public and private companies, including prior CFO roles at AMERISAFE (publicly traded), Fortegra, and IFG Companies. This is a material executive appointment to a C-suite officer position responsible for financial reporting, planning, and capital management.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:38:00.925278+00:00","company_name":"Teladoc Health, Inc.","ticker":"TDOC","filing_date":"2026-08-31"}]}